Dong-A St
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bl… Read more
Dong-A St (170900) - Total Liabilities
Latest total liabilities as of September 2025: ₩747.62 Billion KRW
Based on the latest financial reports, Dong-A St (170900) has total liabilities worth ₩747.62 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dong-A St - Total Liabilities Trend (2013–2024)
This chart illustrates how Dong-A St's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dong-A St Competitors by Total Liabilities
The table below lists competitors of Dong-A St ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ElringKlinger AG
PINK:EGKLF
|
USA | $1.22 Billion |
|
Lict Corporation
PINK:LICT
|
USA | $140.84 Million |
|
PetroVietnam General Services Corp
VN:PET
|
Vietnam | ₫10.90 Trillion |
|
YSB Inc.
F:B1S
|
Germany | €4.50 Billion |
|
Ramkhamhaeng Hospital Public Company Limited
BK:RAM
|
Thailand | ฿22.65 Billion |
|
BioInvent International AB (publ)
PINK:BOVNF
|
USA | $102.10 Million |
|
BANPU POWER
BK:BPP-R
|
Thailand | ฿42.69 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Dong-A St's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dong-A St's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dong-A St (2013–2024)
The table below shows the annual total liabilities of Dong-A St from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩682.93 Billion | +17.52% |
| 2023-12-31 | ₩581.11 Billion | +24.27% |
| 2022-12-31 | ₩467.61 Billion | +1.74% |
| 2021-12-31 | ₩459.61 Billion | +35.75% |
| 2020-12-31 | ₩338.57 Billion | -6.71% |
| 2019-12-31 | ₩362.92 Billion | -1.73% |
| 2018-12-31 | ₩369.31 Billion | +15.94% |
| 2017-12-31 | ₩318.53 Billion | -33.28% |
| 2016-12-31 | ₩477.40 Billion | -6.35% |
| 2015-12-31 | ₩509.77 Billion | -14.11% |
| 2014-12-31 | ₩593.52 Billion | +20.55% |
| 2013-12-31 | ₩492.36 Billion | -- |